Embecta Corp. (NASDAQ:EMBC) Short Interest Update

Embecta Corp. (NASDAQ:EMBC) was the recipient of a significant growth in short interest during the month of February. As of February 27th, there was short interest totaling 4,703,024 shares, a growth of 16.6% from the February 12th total of 4,034,174 shares. Approximately 8.0% of the company’s stock are short sold. Based on an average daily volume of 773,618 shares, the short-interest ratio is currently 6.1 days. Based on an average daily volume of 773,618 shares, the short-interest ratio is currently 6.1 days. Approximately 8.0% of the company’s stock are short sold.

Wall Street Analysts Forecast Growth

EMBC has been the subject of several research analyst reports. BTIG Research reiterated a “buy” rating and set a $25.00 target price on shares of Embecta in a research note on Friday, February 6th. Wall Street Zen raised shares of Embecta from a “buy” rating to a “strong-buy” rating in a report on Saturday, March 7th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Embecta in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $18.50.

Embecta Stock Down 0.6%

Shares of NASDAQ EMBC opened at $8.86 on Thursday. The stock’s 50 day moving average price is $10.60 and its two-hundred day moving average price is $12.45. Embecta has a 52-week low of $8.72 and a 52-week high of $15.55. The stock has a market capitalization of $524.69 million, a P/E ratio of 3.74 and a beta of 1.10.

Embecta (NASDAQ:EMBC) last issued its quarterly earnings results on Thursday, February 5th. The company reported $0.71 earnings per share for the quarter, beating analysts’ consensus estimates of $0.67 by $0.04. The business had revenue of $261.20 million during the quarter, compared to the consensus estimate of $258.07 million. Embecta had a negative return on equity of 26.66% and a net margin of 12.92%.The business’s quarterly revenue was down .3% on a year-over-year basis. During the same period in the previous year, the business earned $0.65 EPS. Embecta has set its FY 2026 guidance at 2.800-3.00 EPS. On average, analysts anticipate that Embecta will post 2.85 EPS for the current year.

Embecta Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Friday, February 27th were given a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 6.8%. The ex-dividend date was Friday, February 27th. Embecta’s dividend payout ratio (DPR) is presently 25.32%.

Hedge Funds Weigh In On Embecta

Several hedge funds and other institutional investors have recently modified their holdings of EMBC. Royal Bank of Canada raised its holdings in shares of Embecta by 38.3% during the first quarter. Royal Bank of Canada now owns 18,201 shares of the company’s stock valued at $232,000 after buying an additional 5,036 shares during the last quarter. AQR Capital Management LLC raised its stake in Embecta by 3.7% during the 1st quarter. AQR Capital Management LLC now owns 225,641 shares of the company’s stock valued at $2,738,000 after acquiring an additional 8,109 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Embecta by 2.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 49,323 shares of the company’s stock worth $629,000 after purchasing an additional 1,159 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Embecta by 4.8% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 172,173 shares of the company’s stock valued at $2,195,000 after purchasing an additional 7,894 shares during the period. Finally, Jane Street Group LLC increased its holdings in shares of Embecta by 224.0% during the first quarter. Jane Street Group LLC now owns 132,688 shares of the company’s stock valued at $1,692,000 after purchasing an additional 91,729 shares during the period. Institutional investors and hedge funds own 93.83% of the company’s stock.

Embecta Company Profile

Embecta Corp (NASDAQ: EMBC) is a pure-play diabetes care company that was spun off from Becton, Dickinson and Company on July 1, 2021. Headquartered in Franklin Lakes, New Jersey, Embecta focuses exclusively on the development, manufacturing and commercialization of products that enable insulin delivery and blood glucose monitoring for people with diabetes.

The company’s product portfolio includes insulin infusion sets, durable and patch pumps, pen needles, infusion tubing, blood glucose test strips, lancets and lancing devices.